Variables | Within 50 days | Within 100 days | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Older age (≥40) | 1.68 | (1.20–2.36) | 0.003 | 1.63 | (1.34–1.98) | < 0.001 |
Diagnosis | ||||||
ALL | Reference | Reference | ||||
AML | 0.75 | (0.54–1.05) | 0.097 | 0.82 | (0.68–1.00) | 0.050 |
Longer D-to-HCT duration (≥9 months) | 2.09 | (1.39–3.13) | < 0.001 | 1.58 | (1.23–2.03) | < 0.001 |
Previous transplantation | 2.51 | (1.55–4.08) | < 0.001 | 1.79 | (1.28–2.49) | 0.001 |
Previous iron chelation therapy | 0.07 | (0.02–0.29) | < 0.001 | 0.17 | (0.10–0.29) | < 0.001 |
Graft source | ||||||
Peripheral blood | Reference | Reference | ||||
Bone marrow | 0.61 | (0.37–1.01) | 0.054 | 0.80 | (0.61–1.04) | 0.097 |
Cord blood | 2.01 | (1.11–3.64) | 0.022 | 2.44 | (1.73–3.45) | < 0.001 |
Use of ATG | 1.07 | (0.77–1.50) | 0.690 | 1.17 | (0.96–1.42) | 0.125 |